A Vanderbilt University Medical Center interim analysis shows that there appears to be a considerable length of time before a subset of people develop inflammatory, scarring lung diseases where there is radiologically detectable evidence they will develop lung disease.
Though he specializes in chronic disease, epidemiologist Qi Dai, MD, PhD, professor of Medicine, has been closely following the international scientific literature on SARS-CoV-2 and the disease it causes, COVID-19 (coronavirus disease 2019). He answered questions on March 19, when total U.S.
Vanderbilt researchers have identified haplotypes, ancestral fragments of DNA, that are associated with hereditary prostate cancer (HPC) in a first-of-its-kind genomic study made possible by the study of prostate cancer patients with family histories of the disease.
A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk, according to a Vanderbilt study published in the Journal of the American Medical Association.
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.
On Feb. 11, the Nashville Veterans Affairs Medical Center (VAMC) dedicated its dialysis unit to William Stone, MD, a nephrologist and professor of Medicine at Vanderbilt University Medical Center, who retired from VUMC and VAMC in December after 50 years.